Healthcare investing often has greater scientific complexity than standard tech venture capital. Theranos is a well-known example of a risky healthcare bet gone wrong, but some experts say other problematic startups are on the horizon. So we asked some of the field's top venture capitalists, executives, and researchers to tell us what could be done to avoid another healthcare investment gone awry. Their advice ranges from basic tips like vetting the science behind a startup's concept to more creative ideas like encouraging founders to problem-solve during an activity like a hike. Click here for more BI Prime stories.